1. Sacks-Davis, R. et al. High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study. PLoS One 8, e80216,
https://doi.org/10.1371/journal.pone.0080216
(2013).
2. World Health Organization. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Available at,
http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1
., Accessed April, 2018. (2017).
3. Liang, T. J. & Ward, J. W. Hepatitis C in Injection-Drug Users - A Hidden Danger of the Opioid Epidemic. N Engl J Med 378, 1169–1171,
https://doi.org/10.1056/NEJMp1716871
(2018).
4. Zibbell, J. E. et al. Increases in hepatitis C virus infection related to injection drug use among persons aged = 30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006–2012. MMWR Morb Mortal Wkly Rep 64, 453–458 (2015).
5. Division of Viral Hepatitis, N. C. f. H. A., Viral Hepatitis, STD, and TB Prevention. Progress toward viral hepatitis elimination in the United States, 2017).